Figure 3. Comparison of the structures of cGMP, sildenafil and other PDE5 inhibitors.
a | The native substrate, cGMP. b | Sildenafil. c | Vardenafil and Tadalafil. cGMP, cyclic guanosine monophosphate; PDE5, phospho-diesterase type 5.
a | The native substrate, cGMP. b | Sildenafil. c | Vardenafil and Tadalafil. cGMP, cyclic guanosine monophosphate; PDE5, phospho-diesterase type 5.